Solid Tumor Therapeutics Market Outlook, Trends And Future Opportunities (2024-2031)

Solid Tumor Therapeutics Market, By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Others (Stem Cell Therapy, Photodynamic Therapy)), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Others (Pancreatic Cancer, Brain Cancer, Ovarian Cancer)), By Route of Administration (Oral, Parenteral, Others (Topical, Transdermal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others (Specialty Pharmacies, Mail Order Pharmacies)), By Mechanism of Action (Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors, Mitotic Inhibitors, Others (Corticosteroids, Monoclonal Antibodies)), By End-User (Hospitals, Specialty Clinics, Cancer Research Institutes, Others (Ambulatory Surgical Centers, Home Healthcare)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

本报告从供需两端对实体肿瘤治疗市场进行了全面审视，涵盖了化疗、靶向治疗、免疫治疗、激素治疗等多种治疗方式（包括干细胞治疗、光动力治疗等），针对肺癌、乳腺癌、结直肠癌、前列腺癌、肝癌、胃癌等多种癌症类型（包括胰腺癌、脑癌、卵巢癌等），通过口服、注射等给药途径（包括局部用药、经皮用药等），通过医院药房、零售药房、在线药房等分销渠道（包括专科药房、邮购药房等），针对烷化剂、抗代谢物、拓扑异构酶抑制剂、有丝分裂抑制剂等作用机制（包括皮质类固醇、单克隆抗体等），针对医院、专科诊所、癌症研究机构等最终用户（包括门诊手术中心、家庭护理等），以及北美、欧洲、亚太、拉丁美洲、中东及非洲等地区，旨在协助决策者作出明智的选择。